m.danquah
Submits third-party assay reports on material purchased directly. Based in Funchal.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
7
n=7
Annotations
0
n=0
Median purity submitted
98.74%
n=7
Suppliers covered
7
n=7
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-042816 | Semaglutide | GGPeps | GGPE-2604-L2151 | VendorInvestigate | 2026-Q2 | 98.38 | 5.14 | — | Buyer-sourced | 0 | PASS |
| AX-2026-042111 | Tirzepatide | JEEP | JEEP-2602-J7978 | PeptideMeter | 2026-Q2 | 98.67 | 4.80 | — | Buyer-sourced | 0 | PASS |
| AX-2026-043159 | GHK-Cu | SSA | SSA-2604-V7731 | Medutest | 2026-Q2 | 98.74 | 4.15 | 107.0 | Buyer-sourced | 1 | FAIL |
| AX-2026-042593 | Tirzepatide | HJ | HJ-2511-B6617 | Janoshik | 2026-Q2 | 98.87 | 5.67 | 106.3 | Buyer-sourced | 0 | PASS |
| AX-2025-019696 | Selank | TFC | TFC-2504-G2332 | Janoshik | 2025-Q3 | 99.20 | 8.89 | 89.8 | Buyer-sourced | 2 | MARGINAL |
| AX-2024-004198 | IGF-1 LR3 | WWB | WWB-2310-A4053 | Medutest | 2024-Q1 | 99.74 | 4.69 | 106.0 | Buyer-sourced | 0 | PASS |
| AX-2024-005175 | Semax | CPC | CPC-2309-M9933 | Medutest | 2024-Q1 | 98.61 | 5.75 | — | Buyer-sourced | 1 | MARGINAL |